Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
07/2012
07/05/2012US20120171198 Use of igg1 immunoglobulins and/or ligands of the cd32 receptor for treating inflammatory diseases and manifestations via the mucosal route
07/05/2012US20120171197 Binding members for interleukin-4 receptor alpha (IL-4Ra) - 173
07/05/2012US20120171196 Monoclonal antibodies that neutralize anthrax toxins
07/05/2012US20120171195 Anti-hla-e antibodies, therapeutic immunomodulatory antibodies to human hla-e heavy chain, useful as ivig mimetics and methods of their use
07/05/2012US20120171194 Method of Cell Differentiation and Uses Therefor in Screening, Diagnosis and Therapy
07/05/2012US20120171193 Diagnostic and Treatment Methods for Characterizing Bacterial Microbiota in Skin Conditions
07/05/2012US20120171154 purification of multi-specific receptors
07/05/2012US20120171130 Mitigation of Animal and Plant Diseases Using Bioavailable Minerals
07/05/2012US20120171123 Uses and compositions for treatment of rheumatoid arthritis
07/05/2012US20120171120 Low affinity blood brain barrier receptor antibodies and uses therefor
07/05/2012US20120171115 Immuno-conjugates and methods for producing them
07/05/2012US20120171114 Anti-cd151 antibodies and their use in the treatment of cancer
07/05/2012CA2834402A1 Clostridium difficile antigens
07/05/2012CA2823453A1 Fluorocarbon-linked peptide formulation
07/05/2012CA2823065A1 Immunostimulatory oligodeoxynucleotides
07/05/2012CA2822939A1 A cross-linking polypeptide that induces apoptosis
07/05/2012CA2822924A1 Roadmap for controlling malaria
07/05/2012CA2822859A1 Pharmaceutical formulation comprising a biopharmaceutical drug
07/05/2012CA2822825A1 Bovine viral diarrhea virus type 1b vaccine compositions and methods
07/05/2012CA2822115A1 Salmonid alphavirus protein e2
07/05/2012CA2821859A1 Inactivated poliovaccine
07/05/2012CA2821111A1 Expression systems
07/05/2012CA2819947A1 Monoclonal antibody recognizing human papillomavirus (hpv) l2 protein and method for measuring hpv-neutralizing antibody titer using the same
07/05/2012CA2754477A1 Method for screening and purifying enterovirus, method for mass-producing enterovirus, and method for manufacturing enterovirus vaccine
07/04/2012EP2471938A2 Recombinant polyvalent vaccine
07/04/2012EP2471937A2 Recombinant polyvalent vaccine
07/04/2012EP2471936A2 Recombinant polyvalent vaccine
07/04/2012EP2471926A2 Immunostimulatory oligodeoxynucleotides
07/04/2012EP2471915A1 Modified peptide vaccine derived from influenza m2
07/04/2012EP2471817A2 Humanized antibody molecules specific for IL-31
07/04/2012EP2471816A1 Multispecific antibodies
07/04/2012EP2471814A1 Anti-vegf monoclonal antibody and pharmaceutical composition comprising said antibody
07/04/2012EP2471813A1 Optimized Fc variants
07/04/2012EP2471805A2 Compositions and assays to specifically detect nucleic acid of influenza virus A or B
07/04/2012EP2471554A1 Pharmaceutical formulation comprising a biopharmaceutical drug
07/04/2012EP2471553A1 An immunogenic composition comprising peptides derived from cytomegalovirus and the use thereof
07/04/2012EP2471552A1 Reassortant influenza viruses
07/04/2012EP2471551A2 Decreasing potential iatrogenic risks associated with influenza vaccines
07/04/2012EP2471550A1 Proteins with improved solubility and methods for producing and using same
07/04/2012EP2471549A1 Adhesin as immunogen against Escherichia coli
07/04/2012EP2471511A1 Liposome formulation suitable for treating or preventing tuberculosis
07/04/2012EP2470671A1 Antikine antibodies that bind to multiple cc chemokines
07/04/2012EP2470567A1 Humanized anti-cdcp1 antibodies
07/04/2012EP2470566A1 Compositions and methods for potentiating interleukin-35
07/04/2012EP2470565A1 Modified variable domain molecules and methods for producing and using same
07/04/2012EP2470563A1 Velocity factor
07/04/2012EP2470561A1 Targeting tissue factor to activated platelets
07/04/2012EP2470554A1 Compositions that induce t cell help
07/04/2012EP2470212A1 Method of treatment of philadelphia chromosome positive leukaemia
07/04/2012EP2470211A1 Antibodies that bind tau oligomers
07/04/2012EP2470210A2 Methods of treatment using anti-oxidized ldl antibodies
07/04/2012EP2470209A1 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
07/04/2012EP2470208A1 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
07/04/2012EP2470207A1 Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide
07/04/2012EP2470206A1 Antibodies against cdcp1 for the treatment of cancer
07/04/2012EP2470205A1 Adjuvant comprising aluminium, oligonucleotide and polycation
07/04/2012EP2470204A2 Hybrid polypeptides including meningococcal fhbp sequences
07/04/2012EP2470203A1 Means and methods for producing artificial capsular polysaccharides of neisseria meningitidis
07/04/2012EP2470202A1 Methods of treating chronic neurogenic inflammation using a modified clostridial toxin
07/04/2012EP2470201A1 Cofactors for thrombin activation of factor vii and uses thereof
07/04/2012EP2470200A1 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
07/04/2012EP2200641B1 Compositions for eliciting an immune response against mycobacterium avium subspecies paratuberculosis
07/04/2012EP2121732B1 Coiled-coil lipopeptide helical bundles and synthetic virus-like particles
07/04/2012EP1758610B1 Methods of treating cancer using il-21 and monoclonal antibody therapy
07/04/2012EP1710309B1 Use of gene ncsag4 for the diagnosis and prevention of neosporosis and as a marker for analysis of the pathogenesis
07/04/2012CN1981195B Analysis of saccharide vaccines without interference
07/04/2012CN1958608B Method for preparing specificity IgY of anti influenza of birds, and preparation
07/04/2012CN1842540B Anti-glypican 3 antibody
07/04/2012CN102549148A Method of preparing plant-derived vlps
07/04/2012CN102549143A Extracellular vesicles derived from gram-positive bacteria, and use thereof
07/04/2012CN102549015A High affinity human antibodies to human angiopoietin-2
07/04/2012CN102549014A Human serum amyloid-A3 antibody and use thereof
07/04/2012CN102549013A Human monoclonal antibody against S. aureus derived alpha-toxin and its use in treating or preventing abscess formation
07/04/2012CN102548617A Bmp-alk3 antagonists and uses for promoting bone growth
07/04/2012CN102548578A 疫苗 Vaccine
07/04/2012CN102548577A Adjuvanted vaccines for protecting against influenza
07/04/2012CN102548573A Use of NKG2D inhibitors for treating cardiovascular and metabolic diseases, such as type 2 diabetes
07/04/2012CN102548572A Vaccines and compositions against streptococcus pneumoniae
07/04/2012CN102548554A Method for treating Th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor
07/04/2012CN102533860A Foot and mouth disease vaccine and preparation method thereof
07/04/2012CN102533823A Antiviral preparation with HSV (Herpes Simplex Virus) amplicon as carrier
07/04/2012CN102533798A Recombinant denovirus for expressing foot-and-mouth disease virus type A empty capsid, and application thereof
07/04/2012CN102533797A Preparation method for recombinant coxsackie virus A16 like particle and applications thereof
07/04/2012CN102533776A Vaccine adjuvant CCL19 as well as preparation method and application thereof
07/04/2012CN102533702A Antidotes for factor XA inhibitors and methods of using the same
07/04/2012CN102533680A Virus-like particles for pseudorabies virus and preparation method for same
07/04/2012CN102533679A Preparation of virus release buffer solution and application thereof
07/04/2012CN102533678A Vivax malaria erythrocytic stage vaccine and preparation method thereof
07/04/2012CN102533677A Malaria vaccine and preparation method thereof
07/04/2012CN102533676A Virus recombinant vaccine A-NDV-LX/14 for newcastle disease and construction method thereof
07/04/2012CN102533675A Recombinant newcastle disease virus LaSota vaccine strain for expressing nipah encephalitis virus F protein
07/04/2012CN102533674A Recombinant duck virus enteritis virus vaccine strain (rDEVul41HA) for expressing avian influenza virus hemagglutinin (HA) genes and construction method as well as application thereof
07/04/2012CN102533673A Chicken infectious bursal disease very virulent cell adapted strain and application thereof
07/04/2012CN102533671A Coxsackie virus A16-type virus strain and applications thereof
07/04/2012CN102533669A Duck byd virus inactivated vaccine and preparation method thereof
07/04/2012CN102533668A Duck flavivirus, and vaccine and kit thereof
07/04/2012CN102533629A Preparation method of avian encephalomyelitis virus VP1 protein subunit vaccine
07/04/2012CN102533572A Virus-like particle hand-foot-and-mouth disease vaccine and preparation method thereof
07/04/2012CN102532324A Preparation and application of brucella gene engineering subunit vaccines
07/04/2012CN102532320A Single-chain antibody of fully-human anti-human interleukin-21 receptor and application thereof
1 ... 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 ... 1823